Impact of Expandable Cryoballoon on Pulmonary Vein Morphology and Treatment Selection in Atrial Fibrillation Ablation
Pacing and Clinical Electrophysiology · 2026-08 · 49 (8) · 1036-1046
DOI: 10.1111/pace.70227 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 31.03.2026. Verfasst von Fumiya Yoneda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Cryosurgery. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cryoballoon (CB) ablation is widely used for pulmonary vein isolation (PVI). A novel CB (POLARx‐FIT) that can be expanded from 28 to 31 mm has recently been introduced. However, its impact on pulmonary vein (PV) morphology, acute lesion characteristics, and treatment selection remains unclear.
Methods
Among 416 consecutive patients undergoing PVI for atrial fibrillation, after excluding radiofrequency catheter ablation (RFCA) cases and CB ablation with Arctic Front Advance, 190 patients were included: a 28 mm CB group (POLARx, N = 122) and a 31 mm CB group (POLARx‐FIT, N = 68). PV morphology was assessed on preoperative computed tomography. Lesion size of the CB was evaluated using post‐ablation voltage mapping.
Results
After introduction of 31 mm CB, the proportion of patients selecting RFCA due to large PV size decreased from 30.7% to 8.3% ( p < 0.01). Left and right superior PV were significantly larger and both left and right PV distance were significantly longer in the 31 mm CB group. The actual PVI lesion area was significantly larger in the 31 mm CB group (28 mm CB: 14.1 ± 3.4 cm 2 , 31 mm CB: 17.5 ± 3.7 cm 2 , p < 0.01). One‐year atrial tachyarrhythmia recurrence was not significantly different between groups ( p = 0.62)
Conclusion
Despite inclusion of patients with larger PVs, the 31 mm CB was associated with a larger PVI lesion, with similar 1‐year recurrence. The introduction of a 31 mm CB expanded CB eligibility and reduced the need for RFCA in the real‐world practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
ORCID-Profile: Fumiya Yoneda
Zitieren
APA
Yoneda, F., Nishiwaki, S., Inoue, T., Morinaga, A., Tanaka, M., Hata, R., Kohjitani, H., Shizuta, S., & Ono, K. (2026). Impact of Expandable Cryoballoon on Pulmonary Vein Morphology and Treatment Selection in Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology, 49(8), 1036-1046. https://doi.org/10.1111/pace.70227
Vancouver
Yoneda F, Nishiwaki S, Inoue T, Morinaga A, Tanaka M, Hata R, et al. Impact of Expandable Cryoballoon on Pulmonary Vein Morphology and Treatment Selection in Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. 2026;49(8):1036-1046. doi:10.1111/pace.70227
BibTeX
@article{Yoneda2026,
author = {Yoneda, Fumiya and Nishiwaki, Shushi and Inoue, Tomoyuki and Morinaga, Akifumi and Tanaka, Munekazu and Hata, Reo and Kohjitani, Hirohiko and Shizuta, Satoshi and Ono, Koh},
title = {Impact of Expandable Cryoballoon on Pulmonary Vein Morphology and Treatment Selection in Atrial Fibrillation Ablation},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
volume = {49},
number = {8},
pages = {1036--1046},
doi = {10.1111/pace.70227}
}
EUVIMED